Report me for selling fake medicine? Why are you crying when your illness relapses?

"By then, Pfizer's stock price will also rise rapidly. Even if it falls back later, it will not be conducive to my current short selling."

After some analysis, Chen Xuan had an idea in his mind.

It seems that even if the project is eventually declared a failure, good news can still be released continuously before the announcement of failure.

In addition, Pfizer's operations are enough to push up the stock price. No one can predict how high it can rise, but it will definitely be much higher than it is now.

So in order not to take any risks, he decided to quit while he was ahead.

End the short selling first, and then consider whether to continue short selling after Pfizer's surge.

Anyway, if he ends his short selling now, he can make a lot of money, so there is no need to take such a big risk.

Chen Xuan is never a hesitant person. Once he has an idea in his mind, he will take action immediately.

Soon, this short selling was also a perfect closed loop without any problems.

"Pfizer's market value has recently evaporated by more than $40 billion, and now it is only $160 billion, a drop of 15 percent."

Looking at these data, Chen Xuan was still very happy.

Although Pfizer's decline rate was not as fast as that of Dasheng Pharmaceutical Group, more money evaporated than that of Dasheng Pharmaceutical Group.

"Twenty billion."

"One short sale yielded 20 billion, a 200% return."

"No wonder Pfizer is so anxious. Their situation is indeed very grim, but can this project really save Pfizer?"

Chen Xuan was also very satisfied with the profits from this short selling.

Pfizer's market value evaporated by more than 200 billion yuan, and he also earned 20 billion yuan from short selling.

This is already a very considerable income. Even after deducting the handling fees and so on, the actual income is more than 100 billion.

Therefore, he had nothing to be dissatisfied with. Few people could achieve such short-selling profits.

It’s also because of this short selling.

This made Chen Xuan understand Pfizer's feelings better.

Faced with such large fluctuations in the stock market, it is difficult to recover from anxiety. Any listed company would be so anxious.

After all, the ups and downs in the stock market are just a number, but if this number lasts too long, it will turn into a real loss of money.

……

……

Pfizer's market value is now nearly 2/3 away from its peak, with more than $200 billion evaporated. How can they not be anxious?

This also means that the wealth of every shareholder has shrunk, and the shrinkage is very serious. It was not so valuable when cashing out before.

If the price doesn't go back up now, these losses will become real losses, not just numbers on paper.

Therefore, it is normal for Pfizer to be anxious.

Faced with such a huge loss, it is understandable that they adopt any rescue strategy.

Next, Pfizer should push up its stock price at any cost and never let it fall again.

Pfizer's current solution is to acquire a pharmaceutical company and directly obtain a patent for an anti-cancer drug.

"Elsilan? Is this the company Pfizer is interested in?"

"This anti-cancer drug developed by a team really looks promising."

"It just feels a bit unreliable to me. The experimental data is too impressive. I wonder how much money Pfizer will spend to acquire this company."

After reading the company's information, Chen Xuan touched his chin and muttered.

Elsilan says it is a company, but in fact it is just a team.

A team founded at American University, later registered as a company, currently has no drugs on the market.

The company's only product is an anti-cancer drug that is currently undergoing clinical trials.

From Phase I to Phase II and finally to Phase III, all clinical trials went very smoothly.

Judging from the clinical trial report released by Elshelan, this is undoubtedly a very successful new drug. Whether it is efficacy or adverse reactions, its performance in all aspects can be called excellent.